Stretchy Brain-mimicking AI BioSensor Tracks Continuously Your Health

It’s a brainy Band-Aid, a smart watch without the watch, and a leap forward for wearable health technologies. Researchers at the University of Chicago’s Pritzker School of Molecular Engineering (PME) have developed a flexible, stretchable computing chip that processes information by mimicking the human brain. The device, described in the journal Matter, aims to change the way health data is processed.

With this work we’ve bridged wearable technology with artificial intelligence and machine learning to create a powerful device which can analyze health data right on our own bodies,” said Sihong Wang, a materials scientist and Assistant Professor of Molecular Engineering.

Today, getting an in-depth profile about your health requires a visit to a hospital or clinic. In the future, Wang said, people’s health could be tracked continuously by wearable electronics that can detect disease even before symptoms appear. Unobtrusive, wearable computing devices are one step toward making this vision a reality.

The future of healthcare that Wang—and many others—envision includes wearable biosensors to track complex indicators of health including levels of oxygen, sugar, metabolites and immune molecules in people’s blood. One of the keys to making these sensors feasible is their ability to conform to the skin. As such skin-like wearable biosensors emerge and begin collecting more and more information in real-time, the analysis becomes exponentially more complex. A single piece of data must be put into the broader perspective of a patient’s history and other health parameters.

Source: https://pme.uchicago.edu/

Who Owns Scientific Data?

The coronavirus pandemic has rekindled a long-standing debate on whether viruses are a nation’s property, and if countries are obliged to share biological samples and scientific data that are key to developing life-saving treatments and vaccines. More than 6.5 million people are reported to have been infected globally, according to a Reuters tally.

China, where the novel coronavirus emerged late last year, shared the viral genetic sequence data (GSD) with the World Health Organization (WHO) in early January. That enabled laboratories around the world to start developing test kits, medications and vaccines.
Since then, however, a war of words has erupted around who gets access to vaccines and treatments first, with outrage over reports the U.S. administration tried to gain access to a potential vaccine being developed by a German firm.

It is morally wrong to think that someone has a stronger claim to a vaccine because they happen to live in a rich country,” said Mark Eccleston-Turner, co-author of a recent paper on the issue of viral sovereignty.

The international legal system encourages countries to look at viruses as their “sovereign resources that can be bargained and bartered away in exchange for future health goods such as vaccines,” he told the Thomson Reuters Foundation.

We need to move away from this model to one where viruses, and the health goods which are developed are seen as public goods, which everyone in the world has equal claim and access to,” said Eccleston-Turner, a lecturer at Britain’s Keele University.

Source: https://news.trust.org/